John Yangchun Hu M.D.

Recommended Articles

• Promising Results for Hodgkin Patients Using This Therapy

  Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...

• This New Zealand Native Beat Cancer Eight Times

  Being diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...

• Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey

  While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• Overcoming Lymphoma: A South Philly Student's Story

  In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...